Where I see patients (2)
My reviews
Selected research
-
Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data.
European urology
-
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort.
European urology focus
-
Multivitamin Use After Prostate Cancer Diagnosis Is Associated with Lower Risk of Recurrence: A Prospective Cohort Study from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
European urology oncology
Clinical trials
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
The proportion of participants with prostate cancer in whom PYLARIFY PET detected previously occult intraprostatic ISUP grade ≥3 lesions as assessed by pathology, or in whom PYLARIFY PET detected the presence of either/or extrapro...
Recruiting
My work
Doctor Q&A: Peter Carroll
Dr. Carroll discusses his path to UCSF, and how he's pioneered active surveillance as a treatment for prostate cancer.
4.9